Glipizide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Glipizide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

GLIPIZIDE DESCRIPTION



Glipizide




CLINICAL PHARMACOLOGY

Mechanism of Action

Pharmacokinetics


Other Effects



PHARMACOKINETICS




INDICATIONS & USAGE



GLIPIZIDE CONTRAINDICATIONS





WARNINGS

SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY




PRECAUTIONS

General

Hemolytic Anemia


Macrovascular Outcomes


Renal and Hepatic Disease


Hypoglycemia


Loss of Control of Blood Glucose



LABORATORY TESTS



INFORMATION FOR PATIENTS



Physician Counseling Information for Patients


DRUG INTERACTIONS





CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Pregnancy Category C



Nonteratogenic Effects


NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE



GLIPIZIDE ADVERSE REACTIONS



Hypoglycemia
PRECAUTIONSOVERDOSAGE

Gastrointestinal


Dermatologic


Hematologic


Metabolic


Endocrine Reactions


Miscellaneous


Laboratory Tests


OVERDOSAGE




DOSAGE & ADMINISTRATION





Initial Dose


Titration


Maintenance

PRECAUTIONS

Patients Receiving Insulin





Patients Receiving Other Oral Hypoglycemic Agents


HOW SUPPLIED











STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Glipizide

Glipizide

Glipizide

Glipizide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-338(NDC:0781-1453)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
GLIPIZIDE GLIPIZIDE 10 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
STARCH, CORN

Product Characteristics

Color Size Imprint Code Shape
white 10 mm GG772 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-338-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074305 2011-06-27


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.